Drug firm Glenmark is recalling two products in the US due to manufacturing issues, according to the US Food and Drug Administration. New Jersey-based Glenmark Pharmaceuticals Inc, USA, a unit of ...

In our study, we found an increased risk of CVE associated with the use of ipratropium bromide in patients with COPD. We found a significant effect of recency of exposure to ipratropium bromide on ...

or nebulization (7%), or ipratropium bromide in a fixed-dose combination with albuterol (38%). Overall, exposure to anticholinergics was associated with a 29% higher risk of CVEs relative to no ...